Not Medicare Enrolled

Dr. Megan Starks, PA-C

Q: Does Dr. Starks receive payments from pharmaceutical companies?

Yes. Dr. Starks received a total of $2,073 from 29 companies across 108 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

Q: What does Data Coverage mean?

Data Coverage (currently Moderate for Dr. Starks) measures how much public federal data is available about a provider. It is not a quality rating. A Very High or High level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A Low or Moderate level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative.

Family Medicine · Dallas, TX

Low-engagement

700 N PEARL ST STE N208, Dallas, TX 75201

2149999355

In practice since 2018 (7 years)

NPI: 1649740549 verify on NPPES ↗

Moderate

DATA COVERAGE

Data in 2 of 4 federal sources

Measures public federal data availability — not provider quality

Informational, not a quality rating. This page presents federal public records about Dr. Starks from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →

Are you Dr. Starks? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Starks

Dr. Megan Starks is a family medicine specialist in Dallas, TX, with 7 years of NPI registration.

Between the years covered by Open Payments, Dr. Starks received a total of $2,073 from 29 pharmaceutical and/or device companies across 108 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Starks is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 7 years in practice $2,073 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗

$2,073

Total received (2021-2024)

Avg $518/year across 4 years

Top 26% in TX for family medicine

Companies

108

Individual payments

All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel

Food, beverages, travel, and lodging — typically low-value

$2,073 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024

$207

2023

$388

2022

$473

2021

$1,005

Payments by company (2024)

Consulting

Speaking

Meals & Travel

Research

Amarin Pharma Inc.

$214

Neurocrine Biosciences, Inc.

$203

AstraZeneca Pharmaceuticals LP

$199

Janssen Pharmaceuticals, Inc

$185

Lilly USA, LLC

$183

ABBVIE INC.

$141

Boehringer Ingelheim Pharmaceuticals, Inc.

$134

Otsuka America Pharmaceutical, Inc.

$133

GlaxoSmithKline, LLC.

$98

Currax Pharmaceuticals LLC

$76

Corium, LLC

$46

Takeda Pharmaceuticals U.S.A., Inc.

$45

ITI, Inc.

$44

Vanda Pharmaceuticals Inc.

$41

Lundbeck LLC

$40

Tris Pharma Inc

$39

CLOZEX MEDICAL INC

$38

AbbVie Inc.

$31

IDORSIA PHARMACEUTICALS US INC

$29

Merck Sharp & Dohme Corporation

$26

Novo Nordisk Inc

$20

Teva Pharmaceuticals USA, Inc.

$17

Biohaven Pharmaceuticals, Inc.

$17

ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)

$15

Mylan Specialty L.P.

$15

Merck Sharp & Dohme LLC

$14

Axsome Therapeutics, Inc.

$14

Supernus Pharmaceuticals, Inc.

$14

Genentech USA, Inc.

Top 3 companies account for 29.7% of total payments

Associated products mentioned in payments ›

AZSTARYS · Austedo XR · Auvelity · Azstarys · BRINTELLIX · CAPLYTA · CONTRAVE · Clozex Skin Closure Device · Dyanavel XR · EMGALITY · FANAPT · FARXIGA · FASENRA · HETLIOZ · INGREZZA · JANUVIA · JARDIANCE · NURTEC ODT · QELBREE · QUVIVIQ · REXULTI · SPRAVATO · STEGLATRO · Saxenda · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · VRAYLAR · Vascepa · Xofluza · Yupelri

Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a family medicine specialist in Dallas?
Compare family medicine physicians in the Dallas area by procedure volume, costs, and industry payment transparency.

Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi

1,624

Per 100K population

62.4

County median income

$74,149

Nearest hospital

BAYLOR SCOTT AND WHITE MEDICAL CENTER UPTOWN
1.1 mi

Data Sources

Provider Registry	✓ NPPES	Weekly updates
Medicare Enrollment	— Not enrolled	N/A
Practice Data	— No data	N/A
Industry Payments	✓ Open Payments	CY 2024
Disciplinary History	— Not public	N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Starks is a family medicine specialist, with low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Starks receive payments from pharmaceutical companies?

Yes. Dr. Starks received a total of $2,073 from 29 companies across 108 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

What does Data Coverage mean?

Data Coverage (currently Moderate for Dr. Starks) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →

Is this data up to date?

Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide

Understanding Family Medicine

Common procedures, typical costs, and what industry payments mean in family medicine.

Same specialty & city

Family Medicine Physicians in Dallas

Browse family medicine physicians in Dallas ranked by procedure volume and transparency data.

Highest volume

Top Family Medicine Physicians in TX

Family medicine physicians ranked by total Medicare services performed statewide.

Industry payments

Pharma Payments to Family Medicine Physicians in TX

Which TX family medicine physicians receive the most from drug and device companies.

By company

Amarin Pharma Inc. Payments to Doctors

See all physicians who received payments from Amarin Pharma Inc.

By company

Neurocrine Biosciences, Inc. Payments to Doctors

See all physicians who received payments from Neurocrine Biosciences, Inc.

By company

AstraZeneca Pharmaceuticals LP Payments to Doctors

See all physicians who received payments from AstraZeneca Pharmaceuticals LP.

About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology